Home

Corrine Savill, Chief Business Officer: Cullinan Therapeutics CGEM Sell · Filed 24/01/24

Trade details

Type
Insider sale
Amount
$177,328.62
Shares · price
14,559 sh · $12.18 a share
Held after
170,115 sh
Trade date
24/01/22
Filed
24/01/24
Days to filing
2 days

Sold 7.9% of holdings

Share of holding sold
7.9%

Cullinan Therapeutics trades, last 26 weeks

What else happened in Cullinan Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/23~24/02/21

Corrine Savill's recent trades

  • Corrine Savill

    Sell10b5-1 planCullinan Therapeutics

    $647.2K

    Filed 24/02/02

  • Corrine Savill

    Sell10b5-1 planCullinan Therapeutics

    $563.6K

    Filed 24/01/30

  • Corrine Savill

    Sell10b5-1 planCullinan Therapeutics

    $265.6K

    Filed 24/01/24

  • Corrine Savill

    Sell10b5-1 planCullinan Therapeutics

    $49.6K

    Filed 24/01/24

Corrine Savill, Chief Officer — sold $177.3K of Cullinan Therapeutics CGEM · 7.9% of holdings · 10b5-1 plan | Whalegun